U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07625644) titled 'Evaluate BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer' on May 21.
Brief Summary: The objective of the study is to evaluate the efficacy and safety of BL-M14D1 in combination with Atezolizumab compared to Standard-of-Care Therapy in adult participants with previously untreated extensive-stage small cell lung cancer (ES-SCLC).
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Small Cell Lung Cancer Extensive Stage
Small-cell Lung Cancer
Small Cell Carcinoma
Sclc
SCLC,Extensive Stage
Lung Cancer
Lung Cancer Metastatic
Lung Cancer Stage IV
Intervention:
DRUG: B...